Kenneth J. Hillan
- Molecular Biology top 0.5%
- Oncology top 0.5%
- Cancer Research top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Immunology top 2%
- Co-authors
- Napoleone FerraraWilliam NovotnyHans‐Peter GerberK. Sue O’SheaMary DowdHelen ChenMark W. MooreLyn Powell-Braxton
- Topics
- Angiogenesis and VEGF in Cancer (16 papers)Liver physiology and pathology (11 papers)Cancer, Hypoxia, and Metabolism (9 papers)
- Cited by
- Cancer ResearchOncologyHepatology
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Kenneth J. Hillan
56 papers receiving 14.1k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Molecular Biology 9.0k
- Oncology 4.2k
- Cancer Research 3.0k
- Pulmonary and Respiratory Medicine 2.5k
- Immunology 1.4k
Countries citing papers authored by Kenneth J. Hillan
This map shows the geographic impact of Kenneth J. Hillan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth J. Hillan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth J. Hillan more than expected).
Fields of papers citing papers by Kenneth J. Hillan
This network shows the impact of papers produced by Kenneth J. Hillan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth J. Hillan. The network helps show where Kenneth J. Hillan may publish in the future.
Co-authorship network of co-authors of Kenneth J. Hillan
This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth J. Hillan. A scholar is included among the top collaborators of Kenneth J. Hillan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth J. Hillan. Kenneth J. Hillan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 79 | |
| 2 | 13 | |
| 3 | 75 | |
| 4 | 146 | |
| 5 | Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapybreakdown → | 763 |
| 6 | Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerbreakdown → | 2007 |
| 7 | 302 | |
| 8 | 153 | |
| 9 | 97 | |
| 10 | 44 | |
| 11 | 295 | |
| 12 | 246 | |
| 13 | 23 | |
| 14 | 243 | |
| 15 | 79 | |
| 16 | Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancerbreakdown → | 645 |
| 17 | 212 | |
| 18 | 4 | |
| 19 | 29 | |
| 20 | 19 |
About Kenneth J. Hillan
Kenneth J. Hillan is a scholar working on Hepatology, Cancer Research and Oncology, having authored 57 papers that have together received 14.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (16 papers), Liver physiology and pathology (11 papers) and Cancer, Hypoxia, and Metabolism (9 papers). The work is most often cited by research in Cancer Research (3.0k citations), Oncology (4.2k citations) and Hepatology (1.1k citations). Kenneth J. Hillan has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Napoleone Ferrara, William Novotny, Hans‐Peter Gerber, K. Sue O’Shea, Mary Dowd, Helen Chen, Mark W. Moore, Lyn Powell-Braxton, Karen Carver-Moore and Gretchen Frantz. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.